27th May 2016
The UK arm of an international clinical trial to find out information on ependymoma has been launched by Cancer Research UK Kids & Teens.
Working in partnership with TK Maxx, the cancer charity will be treating around 150 children the UK up to the age of 22 with the disease.
Researchers in the project are aiming to find the most successful treatment option that has the fewest side effects for patients.
They will also look to learn more about the biological makeup of ependymoma, in order to find better ways to initially diagnose the illness.
The trial will be carried out by children's cancer centres in the UK and it will be an important of the overall international research.
In total, the experiment will be following the health status of more than 500 children throughout 16 countries in order to improve care for this type of brain tumour, which is incredibly complex to treat.
Posted by Jeanette Royston
Health News is provided by Axonn Media in collaboration with Spire Healthcare. Please note that all copy above is ©Axonn Media and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.